Geron (NASDAQ:GERN – Get Rating) released its earnings results on Thursday. The biopharmaceutical company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.02, RTT News reports. Geron had a negative net margin of 23,808.89% and a negative return on equity of 132.71%. The company had revenue of $0.02 million for […]
Related Keywords
V Bryan Lawlis , Goldman Sachs Group , Cerity Partners , Asset Management Inc , Needham Company , Geron Corp , Wells Fargo Company , Life Insurance Co , Get Rating , Directorv Bryan Lawlis , Management Inc , Gate Manager , Wells Fargo , Foster City , Geron Daily , Orgeron , Nasdaq Gern , Egern , Medical , 37416310 , Earnings ,
vimarsana.com © 2020. All Rights Reserved.